Graft Failure after T Cell Depleted HLA Identical Allogeneic Bone Marrow Transplantation: Risk Factors in Leukemic Patients
Authors:
- 1 January 1993
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 11 (5-6) , 359-368
Abstract
In a retrospective analysis of T cell depleted bone marrow transplantation, we have looked at different parameters in order to determine risk-factors of graft-failure after allogeneic bone marrow transplantation for leukemia. Fifty-one patients with acute leukemia or chronic my-eloid leukemia have been analysed. For 33 of them, the pretransplant conditioning regimen consisted of fractionated total body irradiation (TBI) at 12 Gy prior to cyclophosphamide (120 mg/kg). The other patients received various reinforced preparative regimens. T-cell depletion consisted of treating marrow cells with pan-T monoclonal antibodies (CD2+CD3 or CD2-CD5-CD7) followed by complement mediated cytolysis. No post-transplant immu-nosuppressive prophylaxis was administered except for the first nine patients who received Methotrexate alone. In this group of 51 patients, 12 died within 3 months from graft-related complications and 10 developed graft failure (no engraftment or rejection). Among the possible risk factors associated with this failure, two graft-related parameters appeared significant: the number of CFU-GM progenitors and the number of viable T cells injected with the marrow inoculum. No correlation with graft failure was found with other parameters including diagnosis, disease status at transplant, conditioning regimen, age, sex, and CMV status of donor/host pairs. However, the interpretation must remain cautious because of the relatively small samples in each group.Keywords
This publication has 19 references indexed in Scilit:
- Improvement in rejection, engraftment rate and survival without increase in graft‐versus‐host disease by high marrow cell dose in patients transplanted for aplastic anaemiaBritish Journal of Haematology, 1988
- IMPACT OF T-CELL DEPLETION ON OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR STANDARD-RISK LEUKAEMIASThe Lancet, 1987
- ENGRAFTMENT FOLLOWING T-CELL-DEPLETED MARROW TRANSPLANTATIONTransplantation, 1987
- GRAFT REJECTION AND GRAFT-VERSUS-HOST DISEASE: MIRROR IMAGESThe Lancet, 1986
- Graft rejection following HLA matched T‐lymphocyte depleted bone marrow transplantationBritish Journal of Haematology, 1986
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemiaBritish Journal of Haematology, 1983
- Bone-Marrow TransplantationNew England Journal of Medicine, 1975
- Chi-Square Tests with One Degree of Freedom; Extensions of the Mantel-Haenszel ProcedureJournal of the American Statistical Association, 1963
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958